Characterisation of P2Y2 receptors in human vascular endothelial cells using AR-C118925XX, a competitive and selective P2Y2 antagonist

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)
19 Downloads (Pure)


Background and Purpose: There is a lack of potent, selective antagonists at most subtypes of P2Y receptor. The aims of this study were to characterise the pharmacological properties of the proposed P2Y 2 receptor antagonist, AR-C118925XX, and then to use it to determine the role of P2Y 2 receptors in the action of the P2Y 2 agonist, UTP, in human vascular endothelial cells. Experimental Approach: Cell lines expressing native or recombinant P2Y receptors were superfused constantly, and agonist-induced changes in intracellular Ca 2+ levels monitored using the Ca 2+-sensitive fluorescent indicator, Cal-520. This set-up enabled full agonist concentration–response curves to be constructed on a single population of cells. Key Results: UTP evoked a concentration-dependent rise in intracellular Ca 2+ in 1321N1-hP2Y 2 cells. AR-C118925XX (10 nM to 1 μM) had no effect per se on intracellular Ca 2+ but shifted the UTP concentration–response curve progressively rightwards, with no change in maximum. The inhibition was fully reversible on washout. AR-C118925XX (1 μM) had no effect at native or recombinant hP2Y 1, hP2Y 4, rP2Y 6, or hP2Y 11 receptors. Finally, in EAhy926 immortalised human vascular endothelial cells, AR-C118925XX (30 nM) shifted the UTP concentration–response curve rightwards, with no decrease in maximum. Conclusions and Implications: AR-C118925XX is a potent, selective and reversible, competitive P2Y 2 receptor antagonist, which inhibited responses mediated by endogenous P2Y 2 receptors in human vascular endothelial cells. As the only P2Y 2-selective antagonist currently available, it will greatly enhance our ability to identify the functions of native P2Y 2 receptors and their contribution to disease and dysfunction.

Original languageEnglish
Pages (from-to)2894-2904
Number of pages11
JournalBritish Journal of Pharmacology
Issue number16
Early online date22 May 2019
Publication statusPublished - 1 Aug 2019


  • AR-C118925XX
  • P2Y2 receptor
  • competitive antagonist
  • endothelial cells


Dive into the research topics of 'Characterisation of P2Y<sub>2</sub> receptors in human vascular endothelial cells using AR-C118925XX, a competitive and selective P2Y<sub>2</sub> antagonist'. Together they form a unique fingerprint.

Cite this